CS
ONEM

Credit Suisse’s 1Life Healthcare ONEM Stock Holding History

Credit Suisse’s Portfolio ONEM Stock Details ONEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-353,675
Closed -$5.91M – 3936
2022
Q4 		$5.91M Buy
353,675
+26,243
+8% +$443K 0.01% 1202
2022
Q3 		$5.62M Sell
327,432
-3,685,021
-92% -$57.8M 0.01% 1191
2022
Q2 		$31.5M Sell
4,012,453
-10,594
-0.3% -$91K 0.03% 539
2022
Q1 		$44.6M Buy
4,023,047
+53,464
+1% +$599K 0.04% 481
2021
Q4 		$69.7M Sell
3,969,583
-39,871
-1% -$773K 0.04% 498
2021
Q3 		$81.2M Sell
4,009,454
-72,970
-2% -$1.88M 0.04% 443
2021
Q2 		$135M Buy
4,082,424
+458,812
+13% +$17.3M 0.07% 286
2021
Q1 		$142M Buy
3,623,612
+881,468
+32% +$41.4M 0.07% 294
2020
Q4 		$120M Buy
2,742,144
+1,019,623
+59% +$34.8M 0.06% 349
2020
Q3 		$48.9M Buy
1,722,521
+707,477
+70% +$22.3M 0.03% 617
2020
Q2 		$36.9M Buy
1,015,044
+314,542
+45% +$8.86M 0.03% 668
2020
Q1 		$12.7M Buy
+700,502
New +$15.4M 0.01% 1062

Credit Suisse's ONEM Position: Q1 2023 in Review

Credit Suisse sold out of 1Life Healthcare (ONEM) in Q1 2023, closing a stake of 353,675 shares — an estimated $5.91M sold.

Credit Suisse first reported a position in ONEM in Q1 2020 and held it in 12 quarters. The position peaked at $142M in Q1 2021. 0 funds tracked by Wall St. Rank hold ONEM as of Q1 2023.

  • Credit Suisse reported no remaining 1Life Healthcare position as of Q1 2023 after selling out during the quarter.
  • Credit Suisse sold 353,675 1Life Healthcare shares in Q1 2023, an estimated $5.91M.
  • Credit Suisse first reported a position in 1Life Healthcare in Q1 2020 and held it in 12 quarters.
  • Credit Suisse's 1Life Healthcare position peaked at $142M in Q1 2021.
  • 0 funds tracked by Wall St. Rank held 1Life Healthcare as of Q1 2023.

Based on Credit Suisse's 13F filing for Q1 2023, filed 10 May 2023.